Welcome to LookChem.com Sign In|Join Free
  • or
(S)-1-Cbz-2-pyrrolidineacetic acid, also known as (S)-1-Benzyloxycarbonyl-2-pyrrolidineacetic acid, is a chemical compound belonging to the class of pyrrolidine derivatives. It features a chiral center, resulting in two enantiomers, and is widely utilized in organic synthesis and pharmaceutical research. (S)-1-Cbz-2-pyrrolidineacetic acid's Cbz (benzyloxycarbonyl) protecting group on the nitrogen atom safeguards it from unwanted reactions during synthetic processes. (S)-1-Cbz-2-pyrrolidineacetic acid and its derivatives have demonstrated potential pharmacological activities and are being investigated for their therapeutic applications in various diseases.

56633-73-9

Post Buying Request

56633-73-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

56633-73-9 Usage

Uses

Used in Pharmaceutical Research:
(S)-1-Cbz-2-pyrrolidineacetic acid is used as a building block for the synthesis of various pharmaceuticals and bioactive compounds. Its chiral center and Cbz protecting group make it a versatile component in the development of new drugs and therapeutic agents.
Used in Organic Synthesis:
In the field of organic synthesis, (S)-1-Cbz-2-pyrrolidineacetic acid serves as a key intermediate for the creation of complex molecular structures. Its unique properties allow for the formation of a wide range of chemical products with potential applications in various industries.
Used in Drug Development:
(S)-1-Cbz-2-pyrrolidineacetic acid is used as a precursor in the development of new drugs, thanks to its potential pharmacological activities. Its derivatives are being studied for their therapeutic potential in treating various diseases, making it a valuable asset in the pharmaceutical industry.
Used in Bioactive Compound Synthesis:
(S)-1-Cbz-2-pyrrolidineacetic acid is also utilized in the synthesis of bioactive compounds, which have the potential to interact with biological systems and exhibit beneficial effects. This application further highlights the versatility and importance of (S)-1-Cbz-2-pyrrolidineacetic acid in the field of chemistry and pharmaceuticals.

Check Digit Verification of cas no

The CAS Registry Mumber 56633-73-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,6,3 and 3 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 56633-73:
(7*5)+(6*6)+(5*6)+(4*3)+(3*3)+(2*7)+(1*3)=139
139 % 10 = 9
So 56633-73-9 is a valid CAS Registry Number.

56633-73-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-2-{1-[(benzyloxy)carbonyl]pyrrolidin-2-yl}acetic acid

1.2 Other means of identification

Product number -
Other names (S)-1-Cbz-2-pyrrolidineacetic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:56633-73-9 SDS

56633-73-9Relevant academic research and scientific papers

Efficient synthesis of methyl (S)-4-(1-methylpyrrolidin-2-YL)-3-oxobutanoate as the key intermediate for tropane alkaloid biosynthesis with optically acitve form

Katakam, Nanda Kumar,Seifert, Cole W.,D'Auria, John,Li, Guigen

, p. 604 - 613 (2019/08/01)

Methyl (S)-4-(1-methylpyrrolidin-2-yl)-3-oxobutanoate has been synthesized for enzymatic studies on cyclization enzymes during cocaine biosynthesis in Erythroxylum coca plants. During the present new synthesis, L-proline was first protected with Cbz group and reduced to chiral amino alcohol, which were then followed by Swern oxidation, Wittig reaction and decarboxylative condensation. At the last step, N-methylamino acid precursor was treated with 1,1'-carbonyldiimidazole followed by reacting with methyl potassium malonate to give the 3-oxobutanoate in 54% overall yield. This new strategy has proven to avoid obvious racemization of the L-proline chiral center during the synthesis. In addition, six of the eight synthesis steps were performed via GAP chemistry/technology without the use of column chromatography for purification.

Effective methods for the synthesis of N-methyl β-amino acids from all twenty common α-amino acids using 1,3-oxazolidin-5-ones and 1,3-oxazinan-6-ones

Hughes, Andrew B.,Sleebs, Brad E.

, p. 2611 - 2637 (2007/10/03)

N-Methyl β-amino acids are generally required for application in the synthesis of potentially bioactive modified peptides and other oligomers. Previous work highlighted the reductive cleavage of 1,3-oxazolidin-5-ones to synthesise N-methyl α-amino acids. Starting from α-amino acids, two approaches were used to prepare the corresponding N-methyl β-amino acids. First, α-amino acids were converted to N-methyl α-amino acids by the so-called '1,3-oxazolidin-5-one strategy', and these were then homologated by the Arndt-Eistert procedure to afford N-protected N-methyl β-amino acids derived from the 20 common α-amino acids. These compounds were prepared in yields of 23-57% (relative to N-methyl α-amino acid). In a second approach, twelve N-protected α-amino acids could be directly homologated by the Arndt-Eistert procedure, and the resulting β-amino acids were converted to the 1,3-oxazinan-6-ones in 30-45% yield. Finally, reductive cleavage afforded the desired N-methyl β-amino acids in 41-63% yield. One sterically congested β-amino acid, 3-methyl-3-aminobutanoic acid, did give a high yield (95%) of the 1,3-oxazinan-6-one (65), and subsequent reductive cleavage gave the corresponding AIBN-derived N-methyl β-amino acid 61 in 71% yield (Scheme 2). Thus, our protocols allow the ready preparation of all N-methyl β-amino acids derived from the 20 proteinogenic α-amino acids.

Substituted indole compounds having NOS inhibitory activity

-

Page/Page column 78, (2010/11/24)

The present invention features inhibitors of nitric oxide synthase (NOS), particularly those that selectively inhibit neuronal nitric oxide synthase (nNOS) in preference to other NOS isoforms. The NOS inhibitors of the invention, alone or in combination w

Convenient in situ synthesis of nonracemic N-protected β-amino aldehydes from β-amino acids. Applications in Wittig reactions and heterocycle synthesis

Davies, Simon B.,McKervey, M. Anthony

, p. 1229 - 1232 (2007/10/03)

N-Z-γ-amino alcohols derived from nonracemic β-amino acids are smoothly oxidised by manganese dioxide in acetonitrile to afford aldehydes which can be trapped in situ in Wittig reactions with carbonyl-substituted phosphoranes. The application of this methodology to the synthesis of the alkaloids (S)-(+)-N-BOC-coniine, (S)-(-)-coniceine and a pipecoline precursor is described.

The synthesis of a novel benzodiazocine via an intramolecular Staudinger/aza-Wittig cyclization

O'Neil, Ian A.,Murray, Clare L.,Potter, Andrew J.,Kalindjian, S. Barret

, p. 3609 - 3610 (2007/10/03)

The novel pyrrolobenzodiazocine (1) has been prepared by an intramolecular Staudinger/aza Wittig protocol from the precursor azido aldehyde (2) in a remarkable 93% yield. Aldehyde (2) was prepared by coupling protected homoprolinol with 2-azidobenzoic aci

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 56633-73-9